These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9632453)

  • 21. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations.
    Pomp ER; le Cessie S; Rosendaal FR; Doggen CJ
    Br J Haematol; 2007 Oct; 139(2):289-96. PubMed ID: 17897305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral contraceptives and the risk of myocardial infarction.
    Tanis BC; van den Bosch MA; Kemmeren JM; Cats VM; Helmerhorst FM; Algra A; van der Graaf Y; Rosendaal FR
    N Engl J Med; 2001 Dec; 345(25):1787-93. PubMed ID: 11752354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [25-year-old woman with headache and vomiting. Venous sinus thrombosis].
    Surov A; Kornhuber M
    Dtsch Med Wochenschr; 2011 Nov; 136(45):2313-4. PubMed ID: 22048937
    [No Abstract]   [Full Text] [Related]  

  • 24. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
    Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
    Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Activated protein C resistance in factor V disease: how high is the risk of thrombosis?].
    Spannagl M; Schramm W
    Dtsch Med Wochenschr; 1998 Feb; 123(6):137-9. PubMed ID: 9505951
    [No Abstract]   [Full Text] [Related]  

  • 27. APC resistance, oral contraceptive therapy and deep vein thrombosis: settled and unsettled problems.
    Girolami A; Simioni P; Tormene D
    Haematologica; 2000 Mar; 85(3):225-6. PubMed ID: 10702806
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral contraceptive users and screening of factor V Leiden.
    Aznar J; Gilabert J
    Thromb Haemost; 1999 May; 81(5):845-6. PubMed ID: 10365763
    [No Abstract]   [Full Text] [Related]  

  • 29. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
    Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
    Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevalence of genetic prothrombotic factors (factor V Leiden and II20210 prothrombin mutation) in glomerular nephropathies with or without thrombosis].
    Martínez Ara J; Gómez Rioja R; Riñón C; García Muñoz MS; Ruiz Caravaca ML; Miguel JL
    Nefrologia; 2000; 20(2):139-44. PubMed ID: 10853194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of factor V(Q506) and prothrombin 20210 A mutations in an apparently healthy Icelandic population and patients suffering from venous thrombosis.
    Olafsson I; Hjaltadóttir S; Onundarson PT; Pórarinsdóttir R; Haraldsdóttir V
    Thromb Haemost; 1998 Mar; 79(3):685-6. PubMed ID: 9531063
    [No Abstract]   [Full Text] [Related]  

  • 33. [Oral contraceptives and the risk of venous thromboembolism].
    Uchikova E; Malinova M; Milchev N
    Akush Ginekol (Sofiia); 2002; 41(2):46-8. PubMed ID: 12066553
    [No Abstract]   [Full Text] [Related]  

  • 34. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation.
    Margaglione M; D'Andrea G; d'Addedda M; Giuliani N; Cappucci G; Iannaccone L; Vecchione G; Grandone E; Brancaccio V; Di Minno G
    Thromb Haemost; 1998 May; 79(5):907-11. PubMed ID: 9609218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic risk factors for superficial vein thrombosis.
    Martinelli I; Cattaneo M; Taioli E; De Stefano V; Chiusolo P; Mannucci PM
    Thromb Haemost; 1999 Oct; 82(4):1215-7. PubMed ID: 10544900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prothrombin G20210A gene mutation with LightCycler polymerase chain reaction in venous thrombosis and healthy population in the southeast of Turkey.
    Ayyildiz O; Kalkanli S; Batun S; Aybak M; Isikdogan A; Tiftik N; Bolaman Z; Soker M; Muftuoglu E
    Heart Vessels; 2004 Jul; 19(4):164-6. PubMed ID: 15278388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rare case of catastrophic antiphospholipid syndrome triggered by estrogen-containing oral contraceptives in a patient with double heterozygous factor V Leiden and prothrombin G20210A mutations.
    McRae HL; Yang AH; Kruzer K; Scott GA; Refaai MA
    Am J Hematol; 2022 Feb; 97(2):239-242. PubMed ID: 33621390
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetic risk factors of venous thrombosis.
    Franco RF; Reitsma PH
    Hum Genet; 2001 Oct; 109(4):369-84. PubMed ID: 11702218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale.
    Karttunen V; Hiltunen L; Rasi V; Vahtera E; Hillbom M
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):261-8. PubMed ID: 12695749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral contraceptives are a risk factor for cerebral vein thrombosis.
    Martinelli I; Rosendaal FR; Vandenbroucke JP; Mannucci PM
    Thromb Haemost; 1996 Sep; 76(3):477-8. PubMed ID: 8883291
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.